CLINICAL_TRIALS
trial_result
· 2013-08-19
Clinical Trial Update: Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer [Phase 3]
Summary
Phase 3 trial update for albumin-bound paclitaxel (ABI-007) in advanced non-small cell lung cancer.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Celgene | Conditions: Non-Small Cell Lung Carcinoma | Phase 3 | Status: COMPLETED | Results posted: 2013-08-19